In Vitro Stability of Free and Glucuronidated Cannabinoids in Blood and Plasma Following Controlled Smoked Cannabis

被引:46
作者
Scheidweiler, Karl B. [1 ]
Schwope, David M. [1 ,2 ]
Karschner, Erin L. [1 ,2 ]
Desrosiers, Nathalie A. [1 ]
Gorelick, David A. [1 ]
Huestis, Marilyn A. [1 ]
机构
[1] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA
[2] Aegis Sci Corp, Nashville, TN USA
关键词
TANDEM MASS-SPECTROMETRY; WHOLE-BLOOD; DELTA-9-TETRAHYDROCANNABINOL THC; DELTA(9)-TETRAHYDROCANNABINOL; MARIJUANA; URINE; TETRAHYDROCANNABINOL; PHARMACOKINETICS; THCCOOH; USERS;
D O I
10.1373/clinchem.2012.201467
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Blood and plasma cannabinoid stability is important for test interpretation and is best studied in authentic rather than fortified samples. METHODS: Low and high blood and plasma pools were created for each of 10 participants after they smoked a cannabis cigarette. The stabilities of Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), cannabidiol (CBD), cannabinol (CBN), THC-glucuronide, and THCCOOH-glucuronide were determined after 1 week at room temperature; 1, 2, 4, 12, and 26 (+/- 2) weeks at 4 degrees C; and 1, 2, 4, 12, 26 (+/- 2), and 52 (+/- 4) weeks at -20 degrees C. Stability was assessed by Friedman test. RESULTS: Numbers of THC-glucuronide and CBD-positive blood samples were insufficient to assess stability. In blood, 11-OH-THC and CBN were stable for 1 week at room temperature, whereas THC and THCCOOH-glucuronide decreased and THCCOOH increased. In blood, THC, THCCOOH-glucuronide, THCCOOH, 11-OH-THC, and CBN were stable for 12, 4, 4, 12, and 26 weeks, respectively, at 4 degrees C and 12, 12, 26, 26, and 52 weeks at -20 degrees C. In plasma, THC-glucuronide, THC, CBN, and CBD were stable for 1 week at room temperature, whereas THCCOOH-glucuronide and 11-OH-THC decreased and THCCOOH increased. In plasma, THC-glucuronide, THC, THCCOOH-glucuronide, THCCOOH, 11-OH-THC, CBN, and CBD were stable for 26, 26, 2, 2, 26, 12, and 26 weeks, respectively, at 4 degrees C and 52, 52, 26, 26, 52, 52, and 52 weeks, respectively, at -20 degrees C. CONCLUSIONS: Blood and plasma samples should be stored at -20 degrees C for no more than 3 and 6 months, respectively, to assure accurate cannabinoid quantitative results. (C) 2013 American Association for Clinical Chemistry
引用
收藏
页码:1108 / 1117
页数:10
相关论文
共 27 条
[1]   Simultaneous GC-El-MS determination of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-9-carboxy, Δ9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis [J].
Abraham, Tsadik T. ;
Lowe, Ross H. ;
Pirnay, Stephane O. ;
Darwin, William D. ;
Huestis, Marilyn A. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2007, 31 (08) :477-485
[2]   Production of Identical Retention Times and Mass Spectra for Δ9-Tetrahydrocannabinol and Cannabidiol Following Derivatization with Trifluoracetic Anhydride with 1,1,1,3,3,3-Hexafluoroisopropanol [J].
Andrews, Rebecca ;
Paterson, Sue .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (01) :61-65
[3]   TETRAHYDROCANNABINOL STABILITY IN WHOLE-BLOOD - PLASTIC VERSUS GLASS CONTAINERS [J].
CHRISTOPHERSEN, AS .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1986, 10 (04) :129-131
[4]   RELATIONSHIP BETWEEN PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATION AND PHARMACOLOGIC EFFECTS IN MAN [J].
COCCHETTO, DM ;
OWENS, SM ;
PEREZREYES, M ;
DIGUISEPPI, S ;
MILLER, LL .
PSYCHOPHARMACOLOGY, 1981, 75 (02) :158-164
[5]   Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples [J].
Dresen, Sebastian ;
Kneisel, Stefan ;
Weinmann, Wolfgang ;
Zimmermann, Ralf ;
Auwaerter, Volker .
JOURNAL OF MASS SPECTROMETRY, 2011, 46 (02) :163-171
[6]   Δ9-Tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids [J].
Goodivin, Robert S. ;
Gustafson, Richard A. ;
Barnes, Allan ;
Nebro, Wesenyalsh ;
Moolchan, Eric T. ;
Huestis, Marilyn A. .
THERAPEUTIC DRUG MONITORING, 2006, 28 (04) :545-551
[7]   Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts [J].
Grauwiler, Sandra B. ;
Scholer, Andre ;
Drewe, Juergen .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 850 (1-2) :515-522
[8]   ACUTE AND RESIDUAL EFFECTS OF MARIJUANA - PROFILES OF PLASMA THC LEVELS, PHYSIOLOGICAL, SUBJECTIVE, AND PERFORMANCE-MEASURES [J].
HEISHMAN, SJ ;
HUESTIS, MA ;
HENNINGFIELD, JE ;
CONE, EJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (03) :561-565
[9]   Estimating the time of last cannabis use from plasma Δ9-tetrahydrocannabinol and II-nor-9-carboxy-Δ9-tetrahydrocannabinol concentrations [J].
Huestis, MA ;
Barnes, A ;
Smith, ML .
CLINICAL CHEMISTRY, 2005, 51 (12) :2289-2295
[10]   BLOOD CANNABINOIDS .2. MODELS FOR THE PREDICTION OF TIME OF MARIJUANA EXPOSURE FROM PLASMA-CONCENTRATIONS OF DELTA-9-TETRAHYDROCANNABINOL (THC) AND 11-NOR-9-CARBOXY-DELTA-9-TETRAHYDROCANNABINOL (THCCOOH) [J].
HUESTIS, MA ;
HENNINGFIELD, JE ;
CONE, EJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1992, 16 (05) :283-290